The Combination of Trametinib, a MEK Inhibitor, and Temsirolimus, an mTOR Inhibitor, Radiosensitizes Lung Cancer Cells

Seo Yun Kim, Cheol Hyeon Kim(Korea Institute of Radiological and Medical Sciences)
Anticancer Research
June 1, 2021
Cited by 10


Related Papers